FMC Corporation (FMC)
NYSE: FMC · Real-Time Price · USD
14.04
-0.25 (-1.78%)
Mar 6, 2026, 4:00 PM EST - Market closed
Company Description
FMC Corporation, an agricultural sciences company, develops, markets, and sells crop protection chemicals in Latin America, North America, Europe, the Middle East, Africa, and Asia.
The company offers crop protection chemicals, including insecticides, herbicides, and fungicides. It also provides biologicals, crop nutrition, and seed treatment products.
It markets its products through its sales organization and alliance partners, independent distributors, and sales representatives.
The company was founded in 1883 and is headquartered in Philadelphia, Pennsylvania.
FMC Corporation
| Country | United States |
| Founded | 1910 |
| Industry | Agricultural Inputs |
| Sector | Materials |
| Employees | 5,500 |
| CEO | Pierre Brondeau |
Contact Details
Address: FMC Tower at Cira Centre South, 2929 Walnut Street Philadelphia, Pennsylvania 19104 United States | |
| Phone | 215 299 6000 |
| Website | fmc.com |
Stock Details
| Ticker Symbol | FMC |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000037785 |
| CUSIP Number | 302491303 |
| ISIN Number | US3024913036 |
| Employer ID | 94-0479804 |
| SIC Code | 2800 |
Key Executives
| Name | Position |
|---|---|
| Dr. Pierre R. Brondeau Ph.D. | President, Chief Executive Officer and Non-Executive Chairman of the Board |
| Andrew D. Sandifer | Executive Vice President and Chief Financial Officer |
| Jacqueline D. Scanlan | Executive Vice President and Chief Human Resources Officer |
| Vsevolod Rostovtsev Ph.D. | Executive Vice President and Chief Technology Officer |
| Sara Velazquez Ponessa J.D. | Executive Vice President, General Counsel and Corporate Secretary |
| Brian P. Angeli | Executive Vice President and President of North America |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 3, 2026 | PRE 14A | Other preliminary proxy statements |
| Feb 27, 2026 | 10-K | Annual Report |
| Feb 4, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Feb 4, 2026 | 8-K | Current Report |
| Jan 30, 2026 | SCHEDULE 13G/A | Filing |
| Dec 12, 2025 | 8-K | Current Report |
| Dec 9, 2025 | 8-K | Current Report |
| Dec 3, 2025 | 8-K | Current Report |
| Oct 30, 2025 | 10-Q | Quarterly Report |
| Oct 29, 2025 | 8-K | Current Report |